Nuclear magnetic resonance monitoring of treatment and prediction of outcome in multiple sclerosis

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 354, Issue 1390, 1999, Pages 1687-1695

  Miller, David H ^a   Thompson, Alan J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Magnetic resonance imaging; Monitoring treatment; Multiple sclerosis; Predicting outcome

Indexed keywords

EID: 0033615668     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.1999.0512     Document Type: Article

References (112)

1. Allen I. V. & McKeown, S. R. 1979 A histological, histochemical, and biochemical study of the macroscopically normal white matter in multiple sclerosis. J. Neurol. Sci. 41, 81-91.
2. Andersen, O., Lycke, J., Tollesson P. O., Svenningsson, A., Runmarker, B., Linde, A. S., Astrom, M., Gjorstrup, P. & Ekholm, S. 1996 Linomide reduces the rate of active lesions in relapsing remitting multiple sclerosis. Mult. Scler. 1, 348.
3. Arnold, D. L., Matthews, P. M., Francis, G. & Antel, J. 1990 Proton magnetic resonance, spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn. Reson. Med. 14, 154-159.
4. Arnold, D. L., Matthews, P. M., Francis, G., O'Connor, J. & Antel, J. P. 1992 Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann. Neurol. 3, 235-241.
5. Barkhof, F., Scheltens, P., Frequin, S. T., Nauta, J. J., Tas, M. W., Valk, J. & Hommes, O. R. 1992 Relapsing remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. Am. J. Radiol. 159, 1041-1047.
6. Barkhof, F., Filippi, M., Miller, D. H., Scheltens, P., Campi, A., Polman, C. H., Comi G., Ader, H. J., Losseff, N. & Valk, J. 1997a Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120, 2059-2069.
7. Barkhof, F. (and 10 others) 1997b Improving interobserver variation in reporting gadolinium-enhanced MR imaging lesions in MS. Neurology 49, 1682-1688.
8. Beck, R. W., Cleary, P. A., Trobe, J. D., Kaufman, D. I., Kupersmith, M. J., Paty, D. W. & Brown, C. H. 1993 The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N. Engl. J. Med. 329, 1764-1769.
9. Brownell, B. & Hughes, J. T. 1962 The distribution of plaques in the cerebrum in multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 25, 315-320.
10. Bruck, W., Bitsch, A., Kolenda, H., Bruck, Y., Stiefel, M. & Lassmann, H. 1997 Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann. Neurol. 42, 783-793.
11. Clanet, M., Berry, I., Gracia-Mcavilla, D., Rougier, M.-H., Boulanouar, K., Chollet, F. & Manelfe, C. 1996 Functional MRI assessment of motor deficit in multiple sclerosis. Eur. Neurol. 3(Suppl. 4), 2.
12. Davic, C. A., Barker, G. J., Webb, S., Tofts, P. S., Thompson, A. J., Harding, A. E., McDonald, W. I. & Miller, D. H. 1995 Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axonal loss. Brain 118, 1583-1592.
13. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 63, 736-742.
14. Dousset, V., Grossman, R., Ramer, K. N., Schnall, M. D., Young, L. H., Gonzalez Scarano, F., Lavi, E. & Cohen, J. A. 1992 Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterisation with magnetisation transfer imaging. Radiology 182, 483-491.
15. Dousset, V., Brochet, B., Vital, A., Gross, C., Benazzouz, A., Boullerne, A., Bidabe, A. M., Gin, A. M. & Caille, J. M. 1995 Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. Am. J. Neuroradiol. 16, 225-231.
16. Dousset, V., Armand, J. P., Lacoste, D., Mieze, S., Letenneur, L., Dartigues, J. F. & Caill, J. M. 1997 Magnetization transfer study of HIV encephalitis and progressive multifocal leucoencephalopathy. Am. J. Neuroradiol. 18, 895-901.
17. Dousset, V., Gayou, A., Brochet, B. & Caille, J. M. 1998 Early structural changes in acute nascent MS lesions suggesting demyelination and remyelination assessed by in vivo serial quantitative magnetization transfer ratios. Neurology 51, 1150-1155.
18. Durelli, L. (and 11 others) 1994 Chronic, systemic high-dose recombinant interferon alpha-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing remitting multiple sclerosis. Neurology 44, 406-413.
19. Edan, G. (and 16 others) 1997 Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multi-centre study of active disease using MRI and clinical criteria. J. Neurol. Neurosurg. Psychiat. 62, 112-118.
20. European Study Group on Interferon B-1b in Secondary Progressive MS 1998 Placebo controlled multicentre randomised trial of interferon B-1b in treatment of secondary progressive multiple sclerosis. Lancet 352, 1491-1497.
21. Evans, A. C., Frank, J. A., Antel, J. & Miller, D. H. 1997 The role of MRI in clinical trials of multiple sclerosis: comparison of image processing techniques. Ann. Neurol. 41, 125-132.
22. Ferguson, B., Matyszak, M. K., Esiri, M. & Perry, V. H. 1997 Axonal damage in acute multiple sclerosis lesions. Brain 120, 393-399.
23. Filippi, M., Horsfield, M. A., Morrissey, S. P., MacManus, D. G., Rudge, P., McDonald, W. I. & Miller, D. H. 1994 Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 44, 635-644.
24. Filippi, M., Campi, A., Mammi, S., Martinelli, V., Locatelli, T., Scotti, G., Amadio, S., Canal, N. & Comi, G. 1995a Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 58, 31-37.
25. Filippi, M., Campi, A., Martinelli, V., Colombo, B., Yousry, T., Canal, N., Scotti, G. & Comi, G. 1995b Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 59, 540-544.
26. Filippi, M., Horsfield, M. A., Bressi, S., Martinelli, V., Baratti, C., Reganati, P., Campi, A., Miller, D. H. & Comi, G. 1995c Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis. A comparison of techniques. Brain 118, 1593-1600.
27. Filippi, M., Horsfield, M. A., Campi, A., Mammi, S., Pereira, C. & Comi, G. 1995d Resolution dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis. Ann. Neurol. 38, 749-754.
28. Filippi, M. (and 10 others) 1996a Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin echo with fast fluid attenuated inversion recovery. Brain 119, 1349-1355.
29. Filippi, M. (and 10 others) 1996b Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS. Neurology 4, 379-384.
30. Filippi, M., Yousry, T., Horsfield, M. A., Alkadhi, H., Rovaris, M., Campi, A., Voltz, R. & Comi, G. 1996c A high-resolution three-dimensional T1-weighted gradient echo sequence improves the detection of disease activity in multiple sclerosis. Ann. Neurol. 40, 201-207.
31. Filippi, M. (and 12 others) 1998a A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. Brain 121, 2011-2020.
32. Filippi, M. (and 14 others) 1998b Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann. Neurol. 43, 499-506.
33. Gass, A., Barker, G. J., Kidd, D., Thorpe, J. W., MacManus, D., Brennan, A., Tofts, P. S., Thompson, A. J., McDonald, W. I. & Miller, D. H. 1994 Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann. Neurol. 36, 62-67.
34. Gawne-Cain, M. L., O'Riordan, J. I., Thompson, A. J., Moseley, I. F. & Miller, D. H. 1997 Multiple sclerosis lesion detection in the brain: a comparison of fast fluid attenuated inversion recovery and conventional T2 weighted dual spin echo. Neurology 4, 364-370.
35. Gawne-Cain, M. L., O'Riordan, J. I., Coles, A., Newell, B., Thompson, A. J. & Miller, D. H. 1998 MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) with spin echo sequences. J. Neurol. Neurosurg. Psychiat. 64, 197-203.
36. Giovanonni, G., Lai, M., Thorpe, J., Kidd, D., Chamoun, V., Thompson, A. J., Miller, D. H., Feldmann, M. & Thompson, E. J. 1997 Longitudinal study of soluble adhesion molecules in multiple sclerosis. Neurology 48, 1557-1565.
37. Grimaud, J., Lai, M., Thorpe, J. W., Adeleine, P., Wang, L., Barker, G. J., Plummer, D. L., Tofts, P. S., McDonald, W. I. & Miller, D. H. 1996 Evaluation of a computer assisted quantification of MS lesions in cranial MRI. Magn. Reson. Imaging 14, 495-505.
38. Grossman, R. I., Gonzales-Scarano, F., Atlas, S.W., Galetta, S. & Silberberg, D. H. 1986 Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 161, 721-725.
39. Harris, J. O., Frank, J. A., Patronas, N., McFarlin, D. E. & McFarland, H. F. 1991 Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing remitting multiple sclerosis: implications for clinical trials and natural history. Ann. Neurol. 29, 548-555.
40. Hawkins, C. P., Munro, P. M. G., Mackenzie, F., Kesselring, J., Tofts, P. S., du Boulay, E. P. G. H., Langdon, D. N. & McDonald, W. I. 1990 Duration and selectivity of blood brain barrier breakdown. Brain 113, 365-378.
41. IFNB (Inferferon beta β) Study Group, University of British Columbia MS/MRI Analysis Group 1995 Interferon beta-1b in the treatment of MS: final outcome of the randomized controlled trial. Neurology 45, 1277-1285.
42. Jacobs, L. D. (and 25 others) 1996 Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann. Neurol. 39, 285-294.
43. Kapoor, R. (and 11 others) 1998 Effects of methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology 50, 230-237.
44. Kappos, L. 1999 Is MRI a predictor of MS related disability? In Frontiers in multiple sclerosis, vol. 2 (ed. A. Siva, J. Kesselring & A. J. Thompson). London: Martin Dunitz. (In the press.).
45. Karussis, D. M., Meiner, Z., Lehmann, D., Gomori, J. M., Schwarz, A., Linde, A. & Abramsky, O. 1996 Treatment of secondary progressive multiple sclerosis with the immuno-modulator linomide: a double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation. Neurology 47, 341-346.
46. Katz, D., Taubenberger, J. K., Cannella, B., McFarlin, D. E., Raine, C. S. & McFarland, H. F. 1993 Correlation between magnetic resonance imaging findings and lesion development in multiple sclerosis. Ann. Neurol. 34, 661-669.
47. Keiper, M. D., Grossman, R. L., Bolinger, L., Ott, I. L., Mannon, L. J. & Kolson, D. L. 1996 Occult lesions in multiple sclerosis documented at 4T but not at 1.5 T. Radiology 201 (poster), 175.
48. Kidd, D., Thorpe, J. W., Thompson, A. J., Kendall, B. E., Moseley, I., MacManus, D., McDonald, W. I. & Miller, D. H. 1993 Spinal cord MRI using multi-array coils and fast spin echo. H. Findings in multiple sclerosis. Neurology 43, 2632-2637.
49. Kidd, D., Thorpe, J. W., Kendall, B. E., Barker, G. J., Miller, D. H., McDonald, W. I. & Thompson, A. J. 1996 MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 60, 15-19.
50. Kidd, D., Barkhof, F., McConnell, R., Algra, P. R., Allen, I. V. & Revesz, T. 1999 Cortical lesions in multiple sclerosis. Brain 122, 17-26.
51. Koopmans, R. A., Li, D. K. B., Grochowski, E. W., Cutler, P. J. & Paty, D. W. 1989 Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features. Ann. Neurol. 25, 71-81.
52. Lai, H. M., Hodgson, T., Gawne-Cain, M., Webb, S., MacManus, D., McDonald, W. I., Thompson, A. J. & Miller, D. H. 1996 A preliminary study into the sensitivity of disease activity detection by weekly serial magnetic resonance imaging in multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 60, 339-341.
53. Lai, H. M., Davic, C. A., Gass, A., Barker, G. J., Webb, S., Tofts, P. S., Thompson, A. J., McDonald, W. I. & Miller, D. H. 1997 Serial magnetisation transfer ratios in gadolinium enhancing lesions in multiple sclerosis. J. Neurol. 244, 308-311.
54. Leary, S. M., Parker, G. J. M., Stevenson, V. L., Barker, G. J., Miller, D. H. & Thompson, A. J. 1999 Reproducibility of magnetic resonance imaging measurements of spinal cord atrophy: the role of quality assurance. Magn. Reson. Imaging. (In the press.)
55. Losseff, N., Kingsley, D. P. E., McDonald, W. I., Miller, D. H. & Thompson, A. J. 1996a Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis. Mult. Scler. 1, 218-222.
56. Losseff, N. A., Webb, S. L., O'Riordan, J. I., Page, R., Wang, L., Barker, G. J., Tofts, P. S., McDonald, W. I., Miller, D. H. & Thompson, A. J. 1996b Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 119, 701-708.
57. Losseff, N. A., Wang, L., Lai, H. M., Yoo, D. S., Gawne Cain, M. L., McDonald, W. I., Miller, D. H. & Thompson, A. J. 1997 Progressive cerebral atrophy in multiple sclerosis: a serial study. Brain 119, 2009-2019.
58. Lumsden, C. E. 1970 The neuropathology of multiple sclerosis. In The handbook of clinical neurology, vol. 9 (ed. P. J. Vinken & G. W. Bruyn), pp.217-309. Amsterdam: North-Holland.
59. Lycklama a Niejeholt, G. J., Barkhof, F., Scheltens, P., Castelijns, J. A., Ader, H., Van Waesberghe, J. H., Polman, C., Jongen, S. J. & Valk, J. 1997 Diffuse abnormality on magnetic resonance imaging of the spinal cord in multiple sclerosis: relation with clinical subtype and disability. Am. J. Neuroradiol. 18, 1041-1048.
60. McFarland, H. F., Frank, J. A., Albert, P. S., Smith, M. E., Martin, R., Harris, J. O., Patronas, N., Maloni, H. & McFarlin, D. E. 1992 Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann. Neurol. 32, 758-766.
61. MacKay, A., Whittal, K., Adler, J., Li, D., Paty, D. & Graeb, D. 1994 In vivo visualization of myelin water in brain by magnetic resonance. Magn. Reson. Med. 31, 673-677.
62. Mancardi, G. L. (and 11 others) 1998 The effect of copolymer-1 on serial gadolinium-enhanced magnetic resonance scans in relapsing-remitting multiple sclerosis. Neurology 50, 1127-1133.
63. Matthews, P. M., Pioro, E., Narayanan, S., De Stefano, N., Fu, L., Francis, G., Antel, J., Wolfson, C. & Arnold, D. L. 1996 Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 119, 715-722.
64. Miller, D. H. (and 9 others) 1988 Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology 38, 175-179.
65. Miller, D. H., Johnson, G., Tofts, P. S., MacManus, D. G. & McDonald, W. I. 1989 Precise relaxation time measurements of normal appearing white matter in inflammatory central nervous system disease. Magn. Reson. Med. 11, 331-336.
66. Miller, D. H., Barkhof, F. & Nauta, J. J. P. 1993 Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 116, 1077-1094.
67. Miller, D. H., Albert, P. S., Barkhof, F., Francis, G., Frank, J. S., Hodgkinson, S., Lublin, F. D., Paty, D. W., Reingold, S. C. & Simon, J. 1996 Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann. Neurol. 39, 6-16.
68. Miller, D. H., Grossman, R. I., Reingold, S. C. & McFarland, H. F. 1998a The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 121, 2-23.
69. Miller, D. H., Molyneux, P. D., MacManus, D. G., Barker, G. J., European Betaferon Study Group, Wagner, K. 1998b A double-blind, placebo-controlled trial of interferon β-1b in secondary progressive multiple sclerosis: magnetic resonance imaging results. Ann. Neurol. 44, 502.
70. Moll, C., Mourre, C., Lazdunsky, M. & Ulrich, J. 1991 Increase of sodium channels in demyelinated lesions of multiple sclerosis. Brain Res. 556, 311-316.
71. Molyneux, P. D., Wang, L., Lai, M., Barker, G. J., Tofts, P. S., Moseley, I. F. & Miller, D. H. 1997 Quantitative techniques for lesion load measurement in multiple sclerosis: an assessment of the global threshold technique after non uniformity and histogram matching correction. Eur. J. Neurol. 4, 1-6.
72. Molyneux, P. D., Tofts, P. S., Fletcher, A., Gunn, B., Robinson, P., Gallagher, H., Moseley, I. F., Barker, G. J. & Miller, D. H. 1998a Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques. J. Neurol. Neurosurg. Psychiat. 65, 42-47.
73. Molyneux, P. D., Tubridy, N., Parker, G. J. M., Barker, G. J., MacManus, D. G., Tofts, P. S., Moseley, I. F. & Miller, D. H. 1998b The effect of slice thickness on magnetic resonance lesion detection and quantification in multiple sclerosis. Am. J. Neuroradiol. 19, 1715-1720.
74. Moreau, T., Thorpe, J., Miller, D., Moseley, I., Hale, G., Waldmann, H., Clayton, D., Wing, M., Scolding, N. & Compston, A. 1994 Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis. Lancet 344, 298-301.
75. Morrissey, S. P., Miller, D. H., Kendall, B. E., Kingsley, D. P. E., Kelly, M. A., Francis, D. A., MacManus, D. G. & McDonald, W. I. 1993 The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain 116, 135-146.
76. Nauta, J. J. P., Thompson, A. J., Barkhof, F. & Miller, D. H. 1994 Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: statistical power of parallel-groups and cross-over designs. J. Neurol. Sci. 122, 6-14.
77. Nesbit, G. M., Forbes, G. S., Scheithauer, B. W., Okazaki, H. & Rodriguez, M. 1991 Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at post mortem. Radiology 180, 467-474.
78. O'Riordan, J. I., Losseff, N., Phatouros, C., Thompson, A. J., Moseley, I. F., MacManus, D. G., McDonald, W. I. & Miller, D. H. 1998a Asymptomatic spinal cord lesions in clinically isolated optic neuritis, brain stem and spinal cord syndromes suggestive of demyelination. J. Neurol. Neurosurg. Psychiat. 64, 353-357.
79. O'Riordan, J. I., Thompson, A. J., Kingsley, D. P. E., MacManus, D. G., Kendall, B. E., Rudge, P., McDonald, W. I. & Miller, D. H. 1998b The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10 year follow up. Brain 121, 495-503.
80. Ormerod, I. E. C. (and 14 others) 1987 The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. Brain 110, 1579-1616.
81. PRISMS [Prevention of Relapses and Disability by Interferon B-1a Subcutaneously in Multiple Sclerosis Study Group) 1998 Randomised double-blind placebo controlled study of interferon B-1a in relapsing remitting multiple sclerosis. Lancet 352, 1498-1504.
82. Rao, S. M., Leo, G. J., Haughton, V. M., St Aubin-Faubert, P. & Bernardin, L. 1989 Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 39, 161-166.
83. Ron, M. A., Callana, M. M. & Warrington, E. K. 1991 Cognitive abnormalities in multiple sclerosis: a psychometric and MRI study: Psychol. Med. 21, 59-68.
84. Rudick, R. A. (and 15 others) 1996 Clinical outcomes assessment in multiple sclerosis. Ann. Neurol. 40, 469-479.
85. Silver, N. C., Barker, G. J., MacManus, D. G., Thorpe, J. W., Howard, R. S. & Miller, D. H. 1996 Decreased magnetisation transfer ratio due to demyelination: a case of central pontine myelinolysis. J. Neurol. Neurosurg. Psychiat. 61, 208-209.
86. Silver, N., Good, C. D., Barker, G. J., MacManus, D. G., Thompson, A. J., Moseley, I. F., McDonald, W. I. & Miller, D. H. 1997 Sensitivity of contrast enhanced MRI in multiple sclerosis: effects of gadolinium dose, magnetisation transfer contrast and delayed imaging. Brain 120, 1149-1161.
87. Smith, M. E., Stone, L. A., Albert, P. S., Frank, J. A., Martin, R., Armstrong, M., Maloni, H., McFarlin, D. E. & McFarland, H. F. 1993 Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann. Neurol. 33, 480-489.
88. Soderstrom, M., Lindqvist, M., Hillert, J., Kall, T. B. & Link, H. 1994 Optic neuritis: findings on MRI, CSF examination and HLA class II typing in 60 patients and results of short term follow up. J. Neurol. 241, 391-397.
89. Sorensen, P. S., Wanscher, B., Jensen, C. V., Schreiber, K., Blinkenberg, M., Ravnborg, M., Kirsmeier, H., Larsen, V. A. & Lee, M. L. 1998 Intravenous immune globulin G reduces MRI activity in relapsing multiple sclerosis. Neurology 50, 1273-1281.
90. Stevenson, V., Gawne-Cain, M. L., Barker, G. J., Thompson, A. J. & Miller, D. H. 1997 Imaging of the spinal cord and brain in multiple sclerosis, a comparative study between fast flair and fast spin echo. J. Neurol. 244, 119-124.
91. Stevenson, V., Leary, S. M., Losseff, N., Parker, G. J. M., Barker, G. J., Husmani, V., Miller, D. H. & Thompson, A. J. 1998 Spinal cord atrophy and disability in MS. A longitudinal study. Neurology 51, 234-238.
92. Stevenson, V. L. (and 13 others) 1999 A one year serial study of primary and transitional progressive multiple sclerosis. Ann. Neurol. (Submitted.)
93. Stewart, W. A., Hall, L. D., Berry, K., Churg, A., Oger, J., Hashimoto, S. A. & Paty, D. W. 1986 Magnetic resonance imaging (MRI) in multiple sclerosis (MS): pathological correlation in 8 cases. Neurology 36, 320.
94. Stone, L. A., Frank, J. A., Albert, P. S., Bash, C., Smith, M. E., Maloni, H. & McFarland, H. F. 1995 The effect of beta interferon on blood brain barrier disruptions demonstrated by contrast enhanced MRI in relapsing remitting multiple sclerosis. Ann. Neurol. 37, 611-619.
95. Thompson, A. J. & Hobart, J. C. 1998 Multiple sclerosis: assessment of disability and disability scales. J. Neurol. 245, 189-196.
96. Thompson, A. J., Kermode, A. G., MacManus, D. G., Kendall, B. E., Kingsley, D. P. E., Moseley, I. F. & McDonald, W. I. 1990 Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. Br. Med. J. 300, 631-634.
97. Thompson, A. J., Kermode, A. G., Wicks, D., MacManus, D. G., Kendall, B. E., Kingsley, D. P. E. & McDonald, W. I. 1991 Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann. Neurol. 29, 53-62.
98. Thompson, A. J., Miller, D., Youl, B., MacManus, D., Moore, S., Kingsley, D., Kendall, B., Feinstein, A. & McDonald, W. I. 1992 Serial gadolinium enhanced MRI in relapsing remitting multiple sclerosis of varying disease duration. Neurology 42, 60-63.
99. Thompson, A. J., Polman, C. H., Miller, D. H., McDonald, W. I., Brochet, B., Filippi, M., Montalban, X. & De Sa, J. 1997 Primary progressive multiple sclerosis. Brain 120, 1085-1096.
100. Thorpe, J. W. (and 11 others) 1995 Quantitative MRI in optic neuritis: correlation with clinical findings and electro-physiology. J. Neurol. Neurosurg Psychiat. 59, 487-492.
101. Thorpe, J. W., Kidd, D., Moseley, I. F., Kendall, B. E., Thompson, A. J., MacManus, D. G., McDonald, W. I. & Miller, D. H. 1996 Serial gadolinium enhanced MRI of the brain and spinal cord in early relapsing remitting multiple sclerosis. Neurology 46, 373-378.
102. Tofts, P. S., Barker, G. J., Filippi, M., Gawne-Cain, M. & Lai, M. 1997 An oblique cylinder contrast-adjusted (OCCA) phantom to measure the accuracy of MRI brain lesion volume estimation schemes in multiple sclerosis. Magn. Reson. Imaging 15, 183-192.
103. Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mork, S. & Bo, L. 1998 Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278-285.
104. Truyen, L., Van Waesberghe, J. H. T. M., Van Walderveen, M. A. A., Van Oosten, B. W., Polman, C. H., Hommes, O. R., Ader, H. J. & Barkof, F. 1996 Accumulation of hypointense lesions ('black holes') on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 47, 1469-1476.
105. Tubridy, N., Ader, H., Barkhof, F., Thompson, A. J. & Miller, D. H. 1998a Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing remitting and secondary progressive subgroups using placebo-controlled parallel groups. J. Neurol. Neurosurg. Psychiat. 64, 50-55.
106. Tubridy, N., Coles, A., Molyneux, P., Compston, D. A. S., Barkhof, F., Thompson, A. J., McDonald, W. I. & Miller, D. H. 1998b Secondary progressive multiple sclerosis: the relationship between short term MRI activity and clinical features. Brain 121, 225-231.
107. Tubridy, N. (and 14 others) 1999 The effect of anti-24 integrin antibody on brain lesion activity in MS. Neurology 53, 466-472.
108. Udupa, K., Wei, L., Samarasekera, S., Miki, Y., Van Buchem, M. A. & Grossman, R. I. 1997 Multiple sclerosis lesion quantification using fuzzy connectedness. Principles, IEEE Trans. Med. Imaging 16, 598-609.
109. Van Buchem, M. A., Grossman, R. I., Miki, Y., Udupa, J. K., Polansky, M. & McGowan, J. C. 1996 Correlation of quantitative volumetric magnetization transfer ratio measurements with clinical and neuropsychological data in multiple sclerosis. Radiology 201 (poster), 174-175.
110. Werring, D. J., Clark, C. A., Barker, G. J., Thompson, A. J. & Miller, D. H. 1999a Diffusion tensor imaging of lesions and normal appearing while matter in multiple sclerosis. Neurology. (In the press.)
111. Werring, D. J., Miller, D. H., Bullmore, E. T., Barker, G. J., MacManus, D. G., Brammer, M. J., McDonald, W. I. & Thompson, A. J. 1999b Extensive brain activation following recovery from optic neuritis: a pilot study using functional magnetic resonance imaging (fMRI). Proc. Int. Soc. Magn. Reson. Med. 2, 942.
112. Youl, B. D. (and 12 others) 1991 The pathophysiology of optic neuritis: an association of gadolinium leakage with clinical and electrophysiological deficits. Brain 114, 2437-2450.